Results 1 to 2 of 2

Thread: PhotoMedex receives copper peptide technology patents

  1. #1
    Senior Member adyus's Avatar
    Join Date
    Jun 2005
    Location
    somewhere in Europe
    Posts
    242

    Default PhotoMedex receives copper peptide technology patents

    A different topical for the treatment of rosacea...
    http://www.drugresearcher.com/news/n...skin-disorders

    From patent 6,927,206:
    "The utility of the composition of Example 7 was demonstrated in a 12 week study involving 8 human patients. More specifically, the cream of Example 7, containing glycyl-L-histidyl-L-lysine:copper(II), was tested for its effect on rosacea. The cream was applied as a thin film to the face twice each day, once in the morning and once at night.

    At the beginning of the study, and at weeks 6 and 12, the number of inflammatory lesions (papules and pustules) was determined at the beginning of the study, and at weeks 6 and 12. In addition, the overall signs of rosacea were rated during the 12 week study using the following global assessment scale.

    Rosacea Global Score:

    0=Clear: absence of inflammatory sessions, erythema, and telangiectasias
    1=Almost clear: absence of inflammatory lesions, or presence of a few small involuted lesions, trace of erythema, presence or absence of telangiectasias.
    2=Mild: few small inflammatory lesions, mild erythema and presence or absence of telangiectasias.
    3=Moderate: Moderate number of inflammatory lesions, moderate to severe erythema, presence of telangiectasias.
    4=Severe: large number of inflammatory lesions, moderate to severe erythema, presence of telangiectasias.


    The results of the evaluation are shown below for each of the 8 patients enrolled in the study. As shown, application of the cream of Example 7 reduced the total number of lesions for 5 of the 8 patients (63%) treated. The average reduction of lesions for the 5 patients showing an effect was 70%. The overall reduction of lesions for all 8 patients treated was 26%.

    In a similar manner, 4 of the 8 patients showed a 50% decrease in the Rosacea Global Score, going from the "mild" to the "almost clear" category within the 12 week study period, thereby, indicating a response to the peptide copper treatment during that period. "

    Adrian

  2. #2
    Senior Member Warren's Avatar
    Join Date
    Jun 2005
    Location
    NZ
    Posts
    575

    Default

    Here is the link to one of thw two patents. It goes in to all the detail

    USPTO 6,927,206

Similar Threads

  1. Biochemics Patents Vasoactives to Enhance Laser Treatments
    By Melissa W in forum News, research articles and current affairs
    Replies: 0
    Last Post: 31st March 2010, 09:24 AM
  2. Galderma and PhotoMedex Join Together for Photodynamic Therapy
    By college_senior in forum News, research articles and current affairs
    Replies: 0
    Last Post: 12th January 2010, 02:33 PM
  3. Improvements in technology
    By Iotrez in forum Intense pulsed light and laser
    Replies: 1
    Last Post: 26th May 2008, 07:12 PM
  4. List of patents related to rosacea
    By adyus in forum News, research articles and current affairs
    Replies: 8
    Last Post: 3rd January 2007, 01:35 AM
  5. copper-peptide complexes strongly stimulate angiogenesis?
    By tobanonymous in forum Intense pulsed light and laser
    Replies: 0
    Last Post: 9th September 2005, 10:36 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •